[Form 4] Cencora, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Cencora, Inc. (COR) President & CEO and director Robert P. Mauch reported routine equity transactions. On 11/18/2025, he exercised a non-qualified stock option to acquire 3,763 shares of common stock at an exercise price of $86.09 per share. On the same date, he sold 5,096 shares of common stock at a price of $366.64 per share under a pre-arranged Rule 10b5-1 trading plan adopted on 11/15/2024.

After these transactions, Mauch directly beneficially owned 65,746 shares of Cencora common stock and held 11,288 derivative securities in the form of stock options. The option exercised on 11/18/2025 related to a grant that became exercisable in four equal installments on 11/13/2020, 11/13/2021, 11/13/2022 and 11/13/2023.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mauch Robert P.

(Last) (First) (Middle)

1 WEST FIRST AVENUE

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		M		3,763	A	$86.09	70,842	D
Common Stock	11/18/2025		S		5,096(1)	D	$366.64	65,746	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	$86.09	11/18/2025		M			3,763	(2)	11/13/2026	Common Stock	3,763	$0	11,288	D

Explanation of Responses:

1. The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/15/24.

2. Exercisable in four equal installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.

Remarks:

	/s/ Elizabeth S. Campbell, attorney-in-fact for Robert P. Mauch	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cencora (COR) report for Robert P. Mauch?

Robert P. Mauch, President & CEO and director of Cencora, Inc. (COR), reported an option exercise for 3,763 shares of common stock and a sale of 5,096 shares of common stock on 11/18/2025.

At what prices did the Cencora (COR) CEO exercise options and sell shares?

Mauch exercised a non-qualified stock option at an exercise price of $86.09 per share and sold common stock at a price of $366.64 per share on 11/18/2025.

How many Cencora (COR) shares does the CEO own after the reported Form 4 transactions?

Following the reported transactions, Robert P. Mauch directly beneficially owned 65,746 shares of Cencora common stock and held 11,288 derivative securities in the form of stock options.

Was the Cencora (COR) CEO’s stock sale conducted under a Rule 10b5-1 plan?

Yes. The sale of 5,096 shares of Cencora common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by Mauch on 11/15/2024.

What was the source of the Cencora (COR) shares the CEO acquired on 11/18/2025?

The 3,763 shares acquired on 11/18/2025 came from exercising a non-qualified stock option with a conversion or exercise price of $86.09 per share.

When did the Cencora (COR) stock options exercised by the CEO become exercisable?

The non-qualified stock option exercised on 11/18/2025 became exercisable in four equal installments on 11/13/2020, 11/13/2021, 11/13/2022 and 11/13/2023.